Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE
Gupta, RK, Harrison, EM, Ho, A, Docherty, AB, Knight, SR, van, S M, Abubakar, I, Lipman, M, Quartagno, M, Pius, R, Buchan, I, Carson, G, Drake, TM, Investigators, ISARICC & Dark, P 2021, ' Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. ', The Lancet. Respiratory medicine . https://doi.org/10.1016/s2213-2600(20)30559-2 The Lancet. Respiratory Medicine The Lancet Respiratory Medicine Gupta, R K, Harrison, E M, Ho, A, Docherty, A B, Knight, S R, van Smeden, M, Abubakar, I, Lipman, M, Quartagno, M, Pius, R, Buchan, I, Carson, G, Drake, T M, Dunning, J, Fairfield, C J, Gamble, C, Green, C A, Halpin, S, Hardwick, H E, Holden, K A, Horby, P W, Jackson, C, Mclean, K A, Merson, L, Nguyen-Van-Tam, J S, Norman, L, Olliaro, P L, Pritchard, M G, Russell, C D, Scott-Brown, J, Shaw, C A, Sheikh, A, Solomon, T, Sudlow, C, Swann, O V, Turtle, L, Openshaw, P J M, Baillie, J K, Semple, M G, Noursadeghi, M & The ISARIC4C Investigators, 2021, ' Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19 : a prospective cohort study ', The Lancet Respiratory Medicine . https://doi.org/10.1016/S2213-2600(20)30559-2